Organon & Co.

OGN60

$15.28arrow_drop_up2.65%$0.39

OGN60

$15.28

arrow_drop_up2.65%$0.39

Performance History

Key Stats
Open	$14.94
Prev. Close	$14.89
EPS	5.05

Next Earnings Date	Mar 13, 2025

	LOW	HIGH
Day Range	14.90	15.46
52 Week Range	10.83	23.10

Ratios

Revenue	-





EPS	5.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Organon & Co. (OGN)

Organon & Co. (OGN) is a global healthcare company focused on breakthrough solutions to improve women’s health. With a mission to deliver innovative products and services that help women live healthier lives, Organon aims to address unmet medical needs in the areas of contraception, fertility, and menopause. The company is committed to advancing healthcare by developing and commercializing products that empower women to take control of their health and well-being.

Organon’s stock price history reflects the company’s growth and potential. Since its initial public offering (IPO), the stock has gained traction in the market, demonstrating strong performance and investor confidence. The stock has shown resilience in the face of market volatility, reflecting the company’s solid fundamentals and promising future prospects.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO: Mr. Kevin Ali
Headquarters: Jersey City
Employees: 10000
Exchange: NYSE

Keep an eye on Organon & Co.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Organon & Co.'s (OGN) price per share?

The current price per share for Organon & Co. (OGN) is $15.28. The stock has seen a price change of $0.39 recently, indicating a 2.65% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Organon & Co. (OGN)?

For Organon & Co. (OGN), the 52-week high is $23.1, which is 51.18% from the current price. The 52-week low is $10.84, the current price is 41.02% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Organon & Co. (OGN) a growth stock?

Organon & Co. (OGN) has shown an average price growth of -3.66% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Organon & Co. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Organon & Co. (OGN) stock price performance year to date (YTD)?

As of the latest data, Organon & Co. (OGN) has a year-to-date price change of 3.87%. Over the past month, the stock has experienced a price change of -11.27%. Over the last three months, the change has been -33.65%. Over the past six months, the figure is -27.2%.

help

Is Organon & Co. (OGN) a profitable company?

Organon & Co. (OGN) has a net income of $1.02B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 59.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 24.65% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 1.44%, providing insight into the company's sales performance and growth. The gross profit is $3.75B. Operating income is noted at $1.33B. Furthermore, the EBITDA is $1.75B.

help

What is the market capitalization of Organon & Co. (OGN)?

Organon & Co. (OGN) has a market capitalization of $3.94B. The average daily trading volume is 15.25, indicating the stock's liquidity and investor engagement.